Professional Documents
Culture Documents
FDA-Speak Terms
Inspection = Audit Investigator = Auditor
25 Sept. 2003
Frankfurt, Germany
following FDA device regulations: Quality Systems Medical Device Reporting Medical Device Tracking Reports of Corrections and Removals Registration and Listing
25 Sept. 2003 Frankfurt, Germany 3
they distribute
FDA prioritizes inspections by risk and
implantable devices and life supporting and life sustaining devices introduced a new device to the market
Recently Have
past
25 Sept. 2003
Present
credentials (identifies person as an FDA investigator) notice of inspection explaining FDAs legal authority to inspect (only in the U.S.)
Frankfurt, Germany 8
Issue
25 Sept. 2003
an idea of layout, workflow, and areas that may need closer inspection
This helps the investigator
about size and structure of company, who is in charge, what products are manufactured there Review registration and listing Evaluate compliance with FDA regulations using the Quality System Inspection Technique (QSIT)
25 Sept. 2003 Frankfurt, Germany 10
What is QSIT?
www.fda.gov/ora/in spect_ref/igs/qsit/q sitguide.htm
FOO D AND DR UG ADMINISTRATION
August 1999
25 Sept. 2003
Frankfurt, Germany
11
What is QSIT?
Identifies 4 major subsystems to
Design Controls
25 Sept. 2003
13
appointed?
Management reviews conducted?
25 Sept. 2003
Frankfurt, Germany
14
established?
25 Sept. 2003 Frankfurt, Germany 15
identified?
Design outputs or specifications for
device identified?
Design verification conducted? Design validation conducted?
25 Sept. 2003 Frankfurt, Germany 16
completed successfully?
25 Sept. 2003 Frankfurt, Germany 17
What does FDA look for in the Corrective and Preventive Action Subsystem?
CAPA procedures established? Sources of data analyzed to identify
sources?
Investigations conducted to identify root
cause of failures?
25 Sept. 2003
Frankfurt, Germany
18
What does FDA look for in the Corrective and Preventive Action Subsystem?
Nonconforming product controlled? Appropriate corrective actions and
activities?
Management review of CAPA activities?
25 Sept. 2003
Frankfurt, Germany
19
What does FDA look for in the Production and Process Control Subsystem?
Processes are controlled and
monitored?
Any rejects or nonconforming
product?
Equipment adjusted, calibrated and
maintained?
25 Sept. 2003 Frankfurt, Germany 20
What does FDA look for in the Production and Process Control Subsystem?
Manufacturing processes validated
or fully verified?
Software validated? Production employees trained and
qualified?
25 Sept. 2003
Frankfurt, Germany
21
Material
25 Sept. 2003
Frankfurt, Germany
22
with management to discuss the inspection the FDA 483 list of observations of any significant deficiencies the deficiencies
Frankfurt, Germany 23
Present
Discuss
25 Sept. 2003
Office of In Vitro Diagnostic Device Evaluation & Safety Office of Surveillance & Biometrics Office of Systems & Management
Frankfurt, Germany
26
Office of Compliance
Division of Enforcement A
Dental, ENT &
Division of Enforcement B
Cardiovascular &
Ophthalmic Devices
OB/GYN, Gastro &
Neurological Devices
Diagnostic X-ray
Urology Devices
General Hospital
Devices
Electronic Products &
Devices
General Surgery
Devices
Orthopedic, Physical
Devices
25 Sept. 2003
Report or EIR
EIR is sent to the Office of Compliance, Center
findings
Office of Compliance reviewer writes Warning
serious deficiencies identified, and FDA must take action to assure correction
25 Sept. 2003 Frankfurt, Germany 29
Letter
25 Sept. 2003
Frankfurt, Germany
30
Warning Letter
FDA sends Warning Letter
describing manufacturers violations of FDA regulations and requesting a reply within 15 days
25 Sept. 2003
Frankfurt, Germany
31
are put on automatic detention to prevent them from entering the U.S.
25 Sept. 2003 Frankfurt, Germany 32
the Act, all products manufactured at this facility may be detained without physical examination upon entry into the United States. In order to prevent your devices from being detained without physical exam, your firm will need to respond to this Warning Letter (as set forth below) and correct the violations noted in this letter. In addition, the agency usually needs to conduct a follow-up inspection to verify that the appropriate corrections have been implemented.
25 Sept. 2003 Frankfurt, Germany 33
25 Sept. 2003
Frankfurt, Germany
34
Where can I get more information about FDA inspections and regulations?
QSIT:
Where can I get more information about FDA inspections and regulations?
Quality system regulation:
http://www.accessdata.fda.gov/scripts/cdrh/cf docs/cfcfr/CFRSearch.cfm?CFRPart=820
General quality system info:
http://www.fda.gov/cdrh/devadvice/32.html
Investigations Operations Manual:
Where can I get more information about FDA inspections and regulations?
Other medical device regulations:
http://www.fda.gov/cdrh/devadvice/
Division of Small Manufacturers, International
25 Sept. 2003
Frankfurt, Germany
37
Summary
Quality System Inspection Technique (QSIT) How FDA conducts inspections What should a manufacturer do after an
inspection
Warning Letter or Warning Letter + Automatic
Detention
Where to go for more information
25 Sept. 2003 Frankfurt, Germany 38